Since you have now admitted to not averaging down on RAP and this is the example you repeatedly use to validate your ability to review biotech.
Your first post on RAP was July of 2017.
The share price was 30c at the time.
It took 5 years for Pfizer to buy it for half of that share price amount.
"as it gets more "smarter""
The takeover started from 9c not 4c, you liar.
Your average price for RAP is 13.5c, meaning you didn't even believe the fundamentals sub 10c.
Over 5-years investing in the company, you made a 55% gain by averaging down after an offer was made. Well done. You really know how to pick the winners.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
26.5¢ |
Change
-0.010(3.64%) |
Mkt cap ! $76.45M | |||
| Open | High | Low | Value | Volume |
| 27.0¢ | 27.5¢ | 26.0¢ | $429.4K | 1.618M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 17 | 433247 | 26.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 26.5¢ | 28052 | 5 |
View Market Depth
| Last trade - 16.10pm 08/08/2025 (20 minute delay) ? |
| IMU (ASX) Chart |